WIM
KZIA

Westside Investment Management’s Kazia Therapeutics KZIA Stock Holding History

Westside Investment Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Sell
47,585
-2,840
-6% -$34.6K 0.09% 174
2026
Q1 		$375K Buy
50,425
+19,550
+63% +$136K 0.06% 225
2025
Q4 		$213K Buy
+30,875
New +$263K 0.03% 274

Other funds holding KZIA

FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Westside Investment Management's KZIA Position: Q2 2026 in Review

Westside Investment Management reduced its Kazia Therapeutics (KZIA) stake by 5.6% in Q2 2026, selling an estimated $34.6K and leaving 47,585 shares worth $670K. The position accounts for 0.09% of the portfolio, ranked #174.

Westside Investment Management first reported a position in KZIA in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Westside Investment Management held 47,585 shares of Kazia Therapeutics worth $670K as of Q2 2026.
  • Westside Investment Management sold 2,840 Kazia Therapeutics shares in Q2 2026, an estimated $34.6K.
  • Kazia Therapeutics made up 0.09% of Westside Investment Management's portfolio in Q2 2026, its #174 holding.
  • Westside Investment Management first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.